Home
Dashboard
Curated content
Startups & Scaleups
Corporates
Investors
Funding rounds
Exits
Universities
Accelerators
Workspaces
Service providers
More organizations
Matching tool
Investment heatmap
Themes
Reports
Investors
NantKwest
Save
NantKwest
Venture capital
Claimed
Clinical-stage immunotherapy company focused on harnessing the immune system to treat disease.
Overview
Portfolio (0)
Notes
Recent News about NantKwest
Edit
Portfolio analysis